Xinnate (private company)

See something wrong or missing? Let us know
Offices:Lund
Business model: B2B

Xinnate is a pharmaceutical development company in Lund, Sweden developing novel, pharmaceutical therapies based on a pioneering technology of immune modulating peptides, that targets dysfunctional healing by controlling presence of microbials and the complex interplay of inflammatory responses.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 12.99m


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top